Mettler-Toledo International (NYSE:MTD) had its target price increased by Deutsche Bank from $600.00 to $630.00 in a note issued to investors on Thursday. The firm presently has a “hold” rating on the medical instruments supplier’s stock. Deutsche Bank’s target price points to a potential upside of 6.59% from the stock’s previous close.
A number of other equities research analysts have also weighed in on MTD. Robert W. Baird cut their target price on shares of Mettler-Toledo International from $675.00 to $630.00 and set a “neutral” rating on the stock in a research note on Friday, February 9th. Morgan Stanley lifted their target price on shares of Mettler-Toledo International from $550.00 to $580.00 and gave the company an “equal weight” rating in a research note on Friday, February 9th. Citigroup raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and lifted their target price for the company from $685.00 to $692.00 in a research note on Friday, February 9th. Zacks Investment Research lowered shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a research note on Tuesday, November 7th. Finally, Evercore ISI assumed coverage on shares of Mettler-Toledo International in a research note on Wednesday, January 3rd. They set an “in-line” rating and a $625.00 target price on the stock. Seven investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $649.30.
Shares of Mettler-Toledo International (NYSE MTD) traded down $25.19 on Thursday, hitting $591.03. 114,955 shares of the stock were exchanged, compared to its average volume of 161,864. The company has a market cap of $15,935.04, a price-to-earnings ratio of 41.98, a price-to-earnings-growth ratio of 2.59 and a beta of 1.08. The company has a debt-to-equity ratio of 1.75, a current ratio of 1.46 and a quick ratio of 1.09. Mettler-Toledo International has a 52-week low of $471.14 and a 52-week high of $697.26.
In related news, CFO Shawn Vadala sold 300 shares of the business’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $605.20, for a total transaction of $181,560.00. Following the sale, the chief financial officer now owns 5,599 shares of the company’s stock, valued at $3,388,514.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP William P. Donnelly sold 6,000 shares of the business’s stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $612.35, for a total transaction of $3,674,100.00. Following the sale, the executive vice president now directly owns 4,500 shares in the company, valued at approximately $2,755,575. The disclosure for this sale can be found here. Insiders have sold 20,300 shares of company stock worth $12,642,620 in the last three months. 5.20% of the stock is currently owned by insiders.
A number of large investors have recently bought and sold shares of MTD. Aperio Group LLC boosted its stake in Mettler-Toledo International by 6.2% during the third quarter. Aperio Group LLC now owns 18,744 shares of the medical instruments supplier’s stock worth $11,737,000 after acquiring an additional 1,101 shares in the last quarter. Crossmark Global Holdings Inc. purchased a new position in Mettler-Toledo International in the third quarter worth about $2,534,000. New York State Teachers Retirement System raised its holdings in Mettler-Toledo International by 0.7% in the third quarter. New York State Teachers Retirement System now owns 41,491 shares of the medical instruments supplier’s stock worth $25,980,000 after buying an additional 290 shares during the last quarter. Canada Pension Plan Investment Board raised its holdings in Mettler-Toledo International by 260.3% in the third quarter. Canada Pension Plan Investment Board now owns 45,500 shares of the medical instruments supplier’s stock worth $28,490,000 after buying an additional 32,873 shares during the last quarter. Finally, Syntal Capital Partners LLC raised its holdings in Mettler-Toledo International by 15.1% in the third quarter. Syntal Capital Partners LLC now owns 1,215 shares of the medical instruments supplier’s stock worth $760,000 after buying an additional 159 shares during the last quarter. 92.22% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION WARNING: “Mettler-Toledo International (MTD) Price Target Raised to $630.00 at Deutsche Bank” was posted by Ticker Report and is owned by of Ticker Report. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright & trademark legislation. The correct version of this report can be read at https://www.tickerreport.com/banking-finance/3230752/mettler-toledo-international-mtd-price-target-raised-to-630-00-at-deutsche-bank.html.
Mettler-Toledo International Company Profile
Mettler-Toledo International Inc is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications.
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.